Products Details
Indication:
For steroid responsive inflammation of the palpebral and bulba conjunctiva, cornea and anterior segment of the globe.
Dosage & Administration:
DOSAGE AND ADMINISTRATION:
1 to 2 drops instilled into the conjunctival sac 2 to 4 times
daily. During the initial 24 to 48 hours the dosage may be
safely increased to 2 drops every hour. Care should be
taken not to discontinue therapy prematurely.
CONTRAINDICATIONS:
Acute superficial herpes simplex keratitis.
Fungal diseases of ocular structures.
Vaccinia, varicella and most other viral diseases of the
cornea and conjunctiva. Tuberculosis of the eye.
Hypersensitivity to the constituents of this medication.
WARNINGS:
Use of a corticosteroid medication in the treatment of
patients with a history of herpes simplex requires great
caution. Prolonged use may cause increased intraocular
pressure in susceptible individuals resulting in glaucoma,
with damage to the optic nerve, defects in visual acuity
and field of vision; posterior subcapsular cataract
formation; or may aid in the establishment of secondary
ocular infections from fungi or viruses liberated from
ocular tissues.
Various ocular diseases and long-term use of topical
corticosteroids have been known to cause corneal and
scleral thinning. Use of topical corticosteroids in the
presence of thin corneal or scleral tissue may lead to
perforation.
Acute purulent untreated infection of the eye may be
masked or activity enhanced by presence of steroid
medication.
Safety and effectiveness have not been demonstrated in
children of the age group 2 years or below.
USE IN PREGNANCY:
Safety of the use of topical steroids during pregnancy has
not been established.
PRECAUTIONS:
As fungal infections of the cornea are particularly prone
to develop coincidentally with long term local steroid
applications, fungal invasion must be suspected in any
persistent corneal ulcer-intraocular pressure should be
checked frequently.
ADVERSE REACTIONS:
Elevations of intraocular pressure (IOP) with possible
development of glaucoma and infrequent optic nerve
damage, posterior subcapsular cataract formation,
secondary ocular infection from pathogens liberated from
ocular tissues. perforation of the globe and delayed
wound healing.